Vitaros Approval Status
- FDA approved: No
- Brand name: Vitaros
- Generic name: alprostadil
- Previous name: Alprox-TD
- Company: NexMed, Inc.
- Treatment for: Erectile Dysfunction
Vitaros (alprostadil) is a topical vasodilator cream in development for the treatment of erectile dysfunction.
Development Status and FDA Approval Process for Vitaros
|Oct 20, 2008||NexMed Discusses End of Review Meeting for Vitaros|
|Jul 23, 2008||NexMed Receives FDA Response for Topical ED Product|
|Nov 20, 2007||NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product|
|Sep 24, 2007||NexMed Files NDA for Proprietary Erectile Dysfunction Treatment|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.